Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
TNFSF11,Tumor necrosis factor ligand superfamily member 11,Chapter XI Diseases of the digestive system,CHIRHEP_NAS,Inverse variance weighted,2,0.92 [0.9-0.94],1.34106040781702e-11,trans
TNFSF11,Tumor necrosis factor ligand superfamily member 11,Chapter XI Diseases of the digestive system,K11_ALCOLIV,Inverse variance weighted,4,0.88 [0.85-0.91],2.89342580144889e-11,trans
TNFSF11,Tumor necrosis factor ligand superfamily member 11,Chapter XI Diseases of the digestive system,K11_LIVER,Inverse variance weighted,8,0.87 [0.81-0.94],0.000256295277618236,trans
TNFSF11,Tumor necrosis factor ligand superfamily member 11,Chapter VI Diseases of the nervous system,G6_EPIPAROX,Inverse variance weighted,11,0.77 [0.67-0.89],0.000405094715234284,trans
TNFSF11,Tumor necrosis factor ligand superfamily member 11,Chapter XI Diseases of the digestive system,K11_FIBROCHIRLIV,Inverse variance weighted,2,0.91 [0.83-0.99],0.021815998184232,trans
TNFSF11,Tumor necrosis factor ligand superfamily member 11,Chapter X Diseases of the respiratory system,COPD_LATER,Wald ratio,1,0.93 [0.86-1.02],0.118736774060918,trans
TNFSF11,Tumor necrosis factor ligand superfamily member 11,Chapter IX Diseases of the circulatory system,I9_UAP,Inverse variance weighted,24,0.97 [0.93-1.01],0.148768410275915,trans
TNFSF11,Tumor necrosis factor ligand superfamily member 11,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS_OTH,Inverse variance weighted,3,1.11 [0.96-1.27],0.151978985538944,trans
TNFSF11,Tumor necrosis factor ligand superfamily member 11,Chapter XIV Diseases of the genitourinary system,N14_RENALTUB,Wald ratio,1,0.8 [0.59-1.09],0.158884510830663,trans
TNFSF11,Tumor necrosis factor ligand superfamily member 11,Chapter X Diseases of the respiratory system,J10_RESPIRATORY,Inverse variance weighted,15,1.09 [0.96-1.24],0.173410988558472,trans
TNFSF11,Tumor necrosis factor ligand superfamily member 11,Chapter X Diseases of the respiratory system,J10_PNEUMONAS,Wald ratio,1,0.86 [0.69-1.08],0.188619436425152,trans
TNFSF11,Tumor necrosis factor ligand superfamily member 11,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,Wald ratio,1,0.97 [0.92-1.02],0.192166286692378,trans
TNFSF11,Tumor necrosis factor ligand superfamily member 11,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,Inverse variance weighted,21,0.97 [0.92-1.02],0.204861419222088,trans
TNFSF11,Tumor necrosis factor ligand superfamily member 11,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_CONDITION,Wald ratio,1,0.84 [0.61-1.16],0.286891978408139,trans
TNFSF11,Tumor necrosis factor ligand superfamily member 11,Chapter XIV Diseases of the genitourinary system,N14_CHRONKIDNEYDIS,Wald ratio,1,1.04 [0.96-1.12],0.327687536685421,trans
TNFSF11,Tumor necrosis factor ligand superfamily member 11,Chapter V Mental and behavioural disorders,F5_ALCOHOL_DEPENDENCE,Inverse variance weighted,3,1.02 [0.98-1.07],0.359521246228749,trans
TNFSF11,Tumor necrosis factor ligand superfamily member 11,Chapter IX Diseases of the circulatory system,I9_K_CARDIAC,Inverse variance weighted,2,1.05 [0.93-1.2],0.427118119495262,trans
TNFSF11,Tumor necrosis factor ligand superfamily member 11,Chapter V Mental and behavioural disorders,AUD,Inverse variance weighted,6,1.02 [0.97-1.07],0.479160962373643,trans
TNFSF11,Tumor necrosis factor ligand superfamily member 11,Chapter X Diseases of the respiratory system,J10_LOWCHRON,Inverse variance weighted,61,1.02 [0.97-1.07],0.489210962194165,trans
TNFSF11,Tumor necrosis factor ligand superfamily member 11,Chapter VI Diseases of the nervous system,FALLS,Inverse variance weighted,5,0.91 [0.69-1.21],0.530961404015463,trans
TNFSF11,Tumor necrosis factor ligand superfamily member 11,Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,Inverse variance weighted,11,0.98 [0.93-1.04],0.545034427448686,trans
TNFSF11,Tumor necrosis factor ligand superfamily member 11,Chapter V Mental and behavioural disorders,F5_DEPRESSION_DYSTHYMIA,Inverse variance weighted,24,0.97 [0.89-1.06],0.559906404913876,trans
TNFSF11,Tumor necrosis factor ligand superfamily member 11,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_BCKGRND_RETINA,Inverse variance weighted,3,0.99 [0.95-1.03],0.572741009412029,trans
TNFSF11,Tumor necrosis factor ligand superfamily member 11,Chapter X Diseases of the respiratory system,COPD_HOSPITAL_MAIN,Inverse variance weighted,7,0.97 [0.86-1.09],0.581482753249159,trans
TNFSF11,Tumor necrosis factor ligand superfamily member 11,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_IRONDEF_NAS,Inverse variance weighted,7,1.02 [0.94-1.11],0.618727144037763,trans
TNFSF11,Tumor necrosis factor ligand superfamily member 11,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,Wald ratio,1,0.96 [0.83-1.12],0.635411389517698,trans
TNFSF11,Tumor necrosis factor ligand superfamily member 11,Chapter X Diseases of the respiratory system,J10_ASTHMA_EXMORE,Inverse variance weighted,59,1.01 [0.97-1.06],0.640863984830132,trans
TNFSF11,Tumor necrosis factor ligand superfamily member 11,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,Inverse variance weighted,69,0.99 [0.96-1.03],0.695309904612518,trans
TNFSF11,Tumor necrosis factor ligand superfamily member 11,Chapter XI Diseases of the digestive system,K11_OESSTODUO,Wald ratio,1,0.93 [0.61-1.42],0.751651145881342,trans
TNFSF11,Tumor necrosis factor ligand superfamily member 11,Chapter V Mental and behavioural disorders,ALCOHOLMENTAL,Wald ratio,1,0.99 [0.87-1.12],0.833542013579499,trans
TNFSF11,Tumor necrosis factor ligand superfamily member 11,Chapter X Diseases of the respiratory system,ASTHMA_NAS,Inverse variance weighted,13,1.01 [0.94-1.08],0.843113850418333,trans
TNFSF11,Tumor necrosis factor ligand superfamily member 11,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,Inverse variance weighted,3,0.99 [0.93-1.06],0.872405431244575,trans
TNFSF11,Tumor necrosis factor ligand superfamily member 11,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOPOROSIS,Inverse variance weighted,3,0.99 [0.88-1.12],0.921535840266996,trans
TNFSF11,Tumor necrosis factor ligand superfamily member 11,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_IMPLICIT,Wald ratio,1,1 [0.78-1.29],0.995939462947187,trans
